Glycogen engineering improves the starvation resistance of mesenchymal stem cells and their therapeutic efficacy in pulmonary fibrosis
eLife · 2025
DOI: 10.7554/elife.106023 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Yongyue Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systems Biology, Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Glycogen, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation, Pulmonary Fibrosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of science and technology of China, The Natural Science Foundation of China, Public Health and Health Discipline Development, Tsinghua University.
Abstract (Originalsprache)
Mesenchymal stem cells (MSCs) are widely used in regenerative medicine, including the treatment of pulmonary fibrosis. However, implanted MSCs disappear within days, constraining therapeutic efficacy, which is largely attributed to nutrient deprivation. In this study, we established glycogen metabolism engineering strategies in mammalian cells. By expressing a functionally optimized glycogen synthase (GYSmut), MSCs could accumulate large amounts of glycogen rapidly as a reserve substance. Glycogen engineering significantly improved the survival of MSCs during starvation both in vitro and in vivo, enhancing cell viability post-implantation and their therapeutic efficacy in pulmonary fibrosis. Glycogen-engineered MSCs may serve as chassis cells for further applications. Our research highlights the importance of glucose metabolism regulation in cell-based therapy and demonstrates the great potential for the metabolic engineering of MSCs and other therapeutic cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Bioinformatics, Center for Synthetic and Systems Biology, Tsinghua University, Beijing, China.
- School of Life Sciences, Tsinghua University, Beijing, China.
- Xinjiang Stem Cells Special Plateau Disease Engineering Technology Research Center, Kashi, China.
- School of Materials Science and Engineering, Tsinghua University, Beijing, China.
- Department of Medical Genetics and Developmental Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
- State Key Laboratory of Green Biomanufacturing, Beijing, China.
ORCID-Profile: Yongyue Xu, Mamatali Rahman, Qiong Wu
Förderung
- Ministry of science and technology of China
- The Natural Science Foundation of China
- Public Health and Health Discipline Development, Tsinghua University
Zitieren
APA
Xu, Y., Rahman, M., Wang, Z., Zhang, B., Xie, H., Wang, L., Xu, H., Sun, X., Cheng, S., & Wu, Q. (2025). Glycogen engineering improves the starvation resistance of mesenchymal stem cells and their therapeutic efficacy in pulmonary fibrosis. eLife. https://doi.org/10.7554/elife.106023
Vancouver
Xu Y, Rahman M, Wang Z, Zhang B, Xie H, Wang L, et al. Glycogen engineering improves the starvation resistance of mesenchymal stem cells and their therapeutic efficacy in pulmonary fibrosis. eLife. 2025. doi:10.7554/elife.106023
BibTeX
@article{Xu2025,
author = {Xu, Yongyue and Rahman, Mamatali and Wang, Zhaoyan and Zhang, Bo and Xie, Hanqi and Wang, Lei and Xu, Haowei and Sun, Xiaodan and Cheng, Shan and Wu, Qiong},
title = {Glycogen engineering improves the starvation resistance of mesenchymal stem cells and their therapeutic efficacy in pulmonary fibrosis},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.106023}
}
EUVIMED